Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 65201 - 65225 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Resveratrol	Investigational	JUND	3727	upregulated	resveratrol results in increased expression of JUND mRNA	19p13.11	A23857 A23902
Resveratrol	Investigational	JUP	3728	upregulated	resveratrol results in increased expression of JUP mRNA	17q21.2	A23852
Resveratrol	Investigational	KAT2B	8850	upregulated	resveratrol results in increased expression of KAT2B mRNA	3p24.3	A23857
Resveratrol	Investigational	KCNH1	3756	downregulated	resveratrol results in decreased expression of KCNH1 mRNA	1q32.2	A23852
Resveratrol	Investigational	KCNN4	3783	upregulated	resveratrol results in increased expression of KCNN4 mRNA	19q13.31	A23852
Resveratrol	Investigational	KCTD20	222658	upregulated	resveratrol results in increased expression of KCTD20 mRNA	6p21.31	A22289
Resveratrol	Investigational	KDR	3791	downregulated	resveratrol results in decreased expression of KDR mRNA	4q12	A23962
Resveratrol	Investigational	KDR	3791	upregulated	resveratrol results in increased expression of KDR mRNA	4q12	A23962
Resveratrol	Investigational	KIF11	3832	downregulated	resveratrol results in decreased expression of KIF11 mRNA	10q23.33	A23857 A23858
Resveratrol	Investigational	KIF20A	10112	upregulated	resveratrol results in increased expression of KIF20A mRNA	5q31.2	A21103
Resveratrol	Investigational	KIF23	9493	downregulated	resveratrol results in decreased expression of KIF23 mRNA	15q23	A23857
Resveratrol	Investigational	KL	9365	downregulated	resveratrol results in decreased expression of KL mRNA	13q13.1	A21627
Resveratrol	Investigational	KL	9365	upregulated	resveratrol results in increased expression of KL mRNA	13q13.1	A23963
Resveratrol	Investigational	KLF2	10365	upregulated	resveratrol results in increased expression of KLF2 mRNA	19p13.11	A23964 A23848
Resveratrol	Investigational	KLF4	9314	upregulated	resveratrol results in increased expression of KLF4 mRNA	9q31.2	A23861
Resveratrol	Investigational	KLK2	3817	downregulated	resveratrol results in decreased expression of KLK2 mRNA	19q13.33	A21310
Resveratrol	Investigational	KLK3	354	downregulated	resveratrol results in decreased expression of KLK3 mRNA	19q13.33	A23847 A23857 A21310 A20146 A21319 A23965 A23966
Resveratrol	Investigational	KLRK1	22914	upregulated	resveratrol results in increased expression of KLRK1 mRNA	12p13.2	A23967 A23968
Resveratrol	Investigational	KPNA2	3838	downregulated	resveratrol results in decreased expression of KPNA2 mRNA	17q24.2	A23857
Resveratrol	Investigational	KRAS	3845	downregulated	resveratrol results in decreased expression of KRAS mRNA	12p12.1	A22498 A23847 A23854
Resveratrol	Investigational	KRT15	3866	upregulated	resveratrol results in increased expression of KRT15 mRNA	17q21.2	A23852
Resveratrol	Investigational	KRT5	3852	upregulated	resveratrol results in increased expression of KRT5 mRNA	12q13.13	A21627
Resveratrol	Investigational	LDLR	3949	upregulated	resveratrol results in increased expression of LDLR mRNA	19p13.2	A23937
Resveratrol	Investigational	LEF1	51176	downregulated	resveratrol results in decreased expression of LEF1 mRNA	4q25	A23863
Resveratrol	Investigational	LEFTY2	7044	downregulated	resveratrol results in decreased expression of LEFTY2 mRNA	1q42.12	A22289

Displaying entries 65201 - 65225 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability